Deepak Poduval

Deepak Poduval is an Associate Research Scientist in the Department of Medical Oncology and Hematology at the Yale School of Medicine. His research focuses on cancer biology, immunotherapy, and genomic analysis, particularly in renal cell carcinoma and breast cancer. He investigates molecular determinants of treatment response and genomic drivers of tumor progression. His work integrates immunogenomics, epigenetics, and microRNA profiling to uncover mechanisms underlying exceptional therapy responses.

Research interests include: cancer immunotherapy, genomic subtyping of tumors, metabolic pathways in cancer, and regenerative biology models. He has published extensively on renal cancer molecular subtypes, immune checkpoint inhibitors, and novel microRNAs in breast cancer. His studies often involve collaborative analyses with teams led by Braun, Shukla, and others.

Key contributions include identifying metabolic and genomic signatures predictive of immunotherapy outcomes, characterizing novel microRNAs in breast cancer progression, and studying chromatin remodeling factors in transcriptional regulation. His work bridges basic science and clinical applications, aiming to improve precision oncology strategies.